Unaudited Condensed Statement of Cash Flows	6 Months Ended
	Dec. 31, 2020 USD ($)
Cash Flows from Operating Activities:
Net loss	$ (303,070)
Adjustments to reconcile net loss to net cash used in operating activities:
General and administrative expenses paid by Sponsor through note payable	24,589
Change in fair value of derivative warrant liabilities	(184,000)
Financing cost derivative warrant liabilities	314,650
Interest income in cash and cash equivalents held in Trust Account	(3,736)
Changes in operating assets and liabilities:
Prepaid expenses	(161,093)
Accounts payable	41,708
Franchise tax payable	119,452
Accrued Expenses	(1,000)
Net cash used in operating activities	(152,500)
Cash Flows from Investing Activities
Cash deposited in Trust Account	(116,725,000)
Net cash used in investing activities	(116,725,000)
Cash Flows from Financing Activities:
Proceeds received from initial public offering, gross	115,000,000
Proceeds received from private placement	5,525,000
Offering costs paid	(2,535,500)
Net cash provided by financing activities	117,989,500
Net increase in cash	1,112,000
Cash - beginning of the period
Cash - end of the period	1,112,000
Supplemental disclosure of noncash activities:
Offering costs included in accounts payable	37,278
Offering costs included in accrued expenses	86,300
Offering costs included in note payable	77,370
Deferred underwriting commissions in connection with the initial public offering	4,025,000
Initial value of common stock subject to possible redemption	99,596,905
Change in value of common stock subject to possible redemption	$ 1,575,554